BIO-key International (BKYI) Q4 2024 earnings summary

Executive summary

• Net loss reduced by 49% to $4.3 million in 2024, driven by higher gross margin, lower operating costs, and a shift to high-margin core solutions, despite an 11% revenue decline from exiting low-margin services.

• Strategic exit from Swivel Secure and focus on proprietary solutions like PortalGuard IAM and identity-bound biometrics led to a 20% increase in high-margin software license revenue.

• Operating expenses decreased by 6% to $9.7 million and cash burn trimmed by 23% to $2.9 million.

• Key partnerships and contracts secured in education, financial services, and defense sectors, with growing international traction and optimism for 2025 based on strong order demand.

• Secured $3.8 million from warrant exercise, reduced debt to $730,000, and raised additional capital through public offerings and note issuance.

Financial highlights

• 2024 revenue declined 11% year-over-year to $6.9 million, mainly due to exit from low-margin services.

• High-margin software license fee revenue grew 20% to $5.2 million; service fees dropped 50% to $1.1 million; hardware revenue fell 47% to $0.6 million.

• Adjusted gross profit rose to $5.4 million, with gross margin improving to 78% from 64% in 2023.

• Net loss improved to $4.3 million ($2.10/share) from $8.5 million ($15.21/share) in 2023.

• Q4 2024 net loss was $1.6 million, or ($0.53) per share, versus $2.4 million, or ($3.99) per share, in Q4 2023.

Outlook and guidance

• Confident in returning to revenue growth and improved profitability in 2025, with aggressive march toward cash flow break-even and potential quarterly volatility due to timing of large orders.

• Focus remains on cost reduction, expanding high-margin solutions, and exploring new markets and partnerships.

• Anticipate growth in both hardware and services revenue lines in 2025.